NO20042884L - Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater - Google Patents

Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Info

Publication number
NO20042884L
NO20042884L NO20042884A NO20042884A NO20042884L NO 20042884 L NO20042884 L NO 20042884L NO 20042884 A NO20042884 A NO 20042884A NO 20042884 A NO20042884 A NO 20042884A NO 20042884 L NO20042884 L NO 20042884L
Authority
NO
Norway
Prior art keywords
trans
preparation
dibenco
cycloheptal
tetrahydro
Prior art date
Application number
NO20042884A
Other languages
English (en)
Norwegian (no)
Inventor
Bart Petrus Anna Maria Medaer
Hua Mao
Yolande Lydia Lang
Tomasz Kozlecki
Frans Josef Cornel Compernolle
Georges Joseph Cornel Hoornaer
Thierry Brossette
Michel Joseph Mauric Giillaume
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20042884L publication Critical patent/NO20042884L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20042884A 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater NO20042884L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (fr) 2001-12-07 2002-12-02 Preparation de derives de 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furane a fusion trans

Publications (1)

Publication Number Publication Date
NO20042884L true NO20042884L (no) 2004-07-07

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042884A NO20042884L (no) 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Country Status (20)

Country Link
US (2) US6998494B2 (fr)
EP (1) EP1456193B1 (fr)
JP (1) JP4516752B2 (fr)
KR (1) KR20050044329A (fr)
CN (1) CN1293066C (fr)
AT (1) ATE294168T1 (fr)
AU (1) AU2002342926B2 (fr)
BR (1) BR0214068A (fr)
CA (1) CA2468038C (fr)
DE (1) DE60203937T2 (fr)
ES (1) ES2242076T3 (fr)
HR (1) HRP20040490A2 (fr)
HU (1) HUP0402152A3 (fr)
IL (1) IL162349A0 (fr)
MX (1) MXPA04005400A (fr)
NO (1) NO20042884L (fr)
NZ (1) NZ532806A (fr)
PL (1) PL369585A1 (fr)
WO (1) WO2003048146A1 (fr)
ZA (1) ZA200404394B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050044329A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 트랜스-융합된3,3a,8,12b-테트라히드로-2H-디벤조[3,4:6,7]시클로헵타[1,2-b]푸란 유도체의 제조
WO2005013969A1 (fr) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Agent antipsychotique a proprietes favorisant la socialisation
ES2311228T3 (es) * 2004-06-14 2009-02-01 Janssen Pharmaceutica Nv Nuevos derivados tetraciclicos de tetrahidrofurano.
CA2577305C (fr) 2004-08-31 2013-12-17 Janssen Pharmaceutica N.V. Procede de production d'acide 2- (4-fluoro-benzyl) phenyl-acetique
JP4912320B2 (ja) 2004-12-07 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換された四環式テトラヒドロピラン、ピロリジンおよびテトラヒドロチオフェン誘導体
CA2595170C (fr) 2005-01-27 2014-08-05 Janssen Pharmaceutica N.V. Derives heterocycliques tetracycliques de tetrahydrofuranne en tant qu'inhibiteurs de 5ht2 dans le traitement de troubles du systeme nerveux central
NZ564181A (en) 2005-06-17 2010-02-26 Janssen Pharmaceutica Nv Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2196328T3 (es) 1996-04-12 2003-12-16 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos sustituidos.
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
BR0214775A (pt) * 2001-12-07 2004-11-09 Janssen Pharmaceutica Nv Preparação de derivados de 3,3a,8,12b-tetraidro-2h-dibenzo[3,4:6,7]ciclohepta[1,2- b]furano cis-fundidos
KR20050044329A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 트랜스-융합된3,3a,8,12b-테트라히드로-2H-디벤조[3,4:6,7]시클로헵타[1,2-b]푸란 유도체의 제조

Also Published As

Publication number Publication date
CN1293066C (zh) 2007-01-03
WO2003048146A1 (fr) 2003-06-12
HRP20040490A2 (en) 2004-10-31
NZ532806A (en) 2006-01-27
MXPA04005400A (es) 2004-10-11
DE60203937D1 (de) 2005-06-02
CN1602306A (zh) 2005-03-30
HUP0402152A3 (en) 2007-03-28
AU2002342926A1 (en) 2003-06-17
ATE294168T1 (de) 2005-05-15
HK1076461A1 (en) 2006-01-20
PL369585A1 (en) 2005-05-02
ES2242076T3 (es) 2005-11-01
JP2005511691A (ja) 2005-04-28
EP1456193B1 (fr) 2005-04-27
DE60203937T2 (de) 2006-05-11
US20050228043A1 (en) 2005-10-13
HUP0402152A2 (hu) 2005-02-28
AU2002342926B2 (en) 2009-02-26
IL162349A0 (en) 2005-11-20
KR20050044329A (ko) 2005-05-12
US20050014820A1 (en) 2005-01-20
CA2468038A1 (fr) 2003-06-12
ZA200404394B (en) 2005-09-05
EP1456193A1 (fr) 2004-09-15
JP4516752B2 (ja) 2010-08-04
CA2468038C (fr) 2011-04-26
BR0214068A (pt) 2004-10-13
US6998494B2 (en) 2006-02-14

Similar Documents

Publication Publication Date Title
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
AUPR213700A0 (en) Antiviral agents
SE0102616D0 (sv) Novel compounds
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
TNSN07485A1 (fr) Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique
YU94103A (sh) Novi derivati sulfonske kiseline
DE69722004D1 (de) Nukleotidanaloga
NO20042884L (no) Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater
CA2397270A1 (fr) Procede de preparation de 5-cyanophthalide
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
WO2001056992A3 (fr) Derives de dibenzo [b,f]azepine et leur preparation
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
ATE307103T1 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
WO2004065360A3 (fr) Nouveaux derives de piperazine et leur utilisation comme intermediaires de synthese
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
EE200300058A (et) Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel
EP1241167A4 (fr) Derives de 3-ethyl-, 3-propyl-, ou 3-butyl-chromane et -thiochromane
DE69811382D1 (de) Carbapenemderivate und herstellungsverfahren dafür
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
ES2082202T3 (es) Derivados de biciclo(3.3.0)octano, procedimiento para su preparacion y su utilizacion farmaceutica.
FI104078B (fi) Menetelmä terapeuttisesti käyttökelpoisten (3-(1-piperatsinyyli)tieno£2,3-b|- ja -£2,3-c|pyridiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application